|
TQ0155 |
Miglustat hydrochloride
|
NB-DNJ hydrochloride,N-Butyldeoxynojirimycin hydrochloride,OGT918 hydrochloride |
Transferase
|
|
|
|
T35626 |
AMP-Deoxynojirimycin
|
AMP-DNM |
Transferase
,
Glucosidase
|
|
AMP-Deoxynojirimycin (AMP-DNM) is a potent inhibitor of ceramide glucosyltransferase and GCase 2.AMP-Deoxynojirimycin is a potent inhibitor of GlcCer biosynthesis and is used in the study of Parkinson's and diabetes. |
|
T4473 |
Ibiglustat
|
Venglustat,SAR402671,GZ402671 |
Transferase
|
|
Ibiglustat (GZ402671) is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. Ibiglustat blocks the formation of glucosylceramide (GL-1), a key intermediate in the synthe... |
|
T70347 |
Ibiglustat hydrochloride
|
|
|
|
Ibiglustat hydrochloride is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. |
|
T38489 |
D,L-erythro-PDMP
|
|
|
|
D,L-erythro-PDMP, an erythro isomer of PDMP, exhibits growth inhibition on cultured rabbit skin fibroblasts. Additionally, this compound serves as an effective inhibitor of UDP-glucose: ceramide glucosyltransferase. |
|
T36319 |
C6 L-erythro Ceramide (d18:1/6:0)
|
C6 L-erythro Ceramide (d18:1/6:0) |
|
|
C6 L-erythro Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. It is metabolized by ceramide glucosyltransferase to form C6 L-erythro glucosylceramide. C6 L-erythro Ceramide... |
|
T36320 |
C6 L-threo Ceramide (d18:1/6:0)
|
C6 L-threo Ceramide (d18:1/6:0) |
|
|
C6 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 L-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). It is metabolically inactive and, unlik... |
|
T37565 |
C6 D-threo Ceramide (d18:1/6:0)
|
C6 D-threo Ceramide (d18:1/6:0) |
|
|
C6 D-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 D-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). It is metabolically inactive and, unlik... |
|
T70336 |
Nizubaglustat
|
|
|
|
Nizubaglustat acts as an inhibitor of Ceramide Glucosyltransferase, also known as Glucosylceramide Synthase (GCS), and additionally inhibits GBA2, which is involved in neuropathological lysosomal storage disorders. |
